Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
NYMPHAEOL A
ID: ALA223256
Max Phase: Preclinical
Molecular Formula: C25H28O6
Molecular Weight: 424.49
Molecule Type: Small molecule
Associated Items:
ID: ALA223256
Max Phase: Preclinical
Molecular Formula: C25H28O6
Molecular Weight: 424.49
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)=CCC/C(C)=C/Cc1c(O)cc2c(c1O)C(=O)C[C@@H](c1ccc(O)c(O)c1)O2
Standard InChI: InChI=1S/C25H28O6/c1-14(2)5-4-6-15(3)7-9-17-19(27)12-23-24(25(17)30)21(29)13-22(31-23)16-8-10-18(26)20(28)11-16/h5,7-8,10-12,22,26-28,30H,4,6,9,13H2,1-3H3/b15-7+/t22-/m0/s1
Standard InChI Key: XCYSQFHYFNWYFP-CEMXSPGASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 424.49 | Molecular Weight (Monoisotopic): 424.1886 | AlogP: 5.45 | #Rotatable Bonds: 6 |
Polar Surface Area: 107.22 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 7.67 | CX Basic pKa: | CX LogP: 5.92 | CX LogD: 5.73 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.36 | Np Likeness Score: 2.31 |
1. Yoder BJ, Cao S, Norris A, Miller JS, Ratovoson F, Razafitsalama J, Andriantsiferana R, Rasamison VE, Kingston DG.. (2007) Antiproliferative prenylated stilbenes and flavonoids from Macaranga alnifolia from the Madagascar rainforest., 70 (3): [PMID:17326683] [10.1021/np060484y] |
2. Smejkal K, Grycová L, Marek R, Lemière F, Jankovská D, Forejtníková H, Vanco J, Suchý V.. (2007) C-geranyl compounds from Paulownia tomentosa fruits., 70 (8): [PMID:17625893] [10.1021/np070063w] |
3. Smejkal K, Chudík S, Kloucek P, Marek R, Cvacka J, Urbanová M, Julínek O, Kokoska L, Slapetová T, Holubová P, Zima A, Dvorská M.. (2008) Antibacterial C-geranylflavonoids from Paulownia tomentosa Fruits., 71 (4): [PMID:18293924] [10.1021/np070446u] |
4. Murphy BT, Cao S, Norris A, Miller JS, Ratovoson F, Andriantsiferana R, Rasamison VE, Kingston DG.. (2005) Cytotoxic flavanones of Schizolaena hystrix from the Madagascar rainforest., 68 (3): [PMID:15787448] [10.1021/np049639x] |
5. Phommart S, Sutthivaiyakit P, Chimnoi N, Ruchirawat S, Sutthivaiyakit S.. (2005) Constituents of the leaves of Macaranga tanarius., 68 (6): [PMID:15974621] [10.1021/np0500272] |
6. Smejkal K, Svacinová J, Slapetová T, Schneiderová K, Dall'acqua S, Innocenti G, Závalová V, Kollár P, Chudík S, Marek R, Julínek O, Urbanová M, Kartal M, Csöllei M, Dolezal K.. (2010) Cytotoxic activities of several geranyl-substituted flavanones., 73 (4): [PMID:20192247] [10.1021/np900681y] |
7. Cho JK, Ryu YB, Curtis-Long MJ, Ryu HW, Yuk HJ, Kim DW, Kim HJ, Lee WS, Park KH.. (2012) Cholinestrase inhibitory effects of geranylated flavonoids from Paulownia tomentosa fruits., 20 (8): [PMID:22445674] [10.1016/j.bmc.2012.02.044] |
8. Cho JK, Curtis-Long MJ, Lee KH, Kim DW, Ryu HW, Yuk HJ, Park KH.. (2013) Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa., 21 (11): [PMID:23623680] [10.1016/j.bmc.2013.03.027] |
9. Hošek J, Toniolo A, Neuwirth O, Bolego C.. (2013) Prenylated and geranylated flavonoids increase production of reactive oxygen species in mouse macrophages but inhibit the inflammatory response., 76 (9): [PMID:23947936] [10.1021/np400242e] |
10. Hanáková Z, Hošek J, Babula P, Dall'Acqua S, Václavík J, Šmejkal K.. (2015) C-Geranylated Flavanones from Paulownia tomentosa Fruits as Potential Anti-inflammatory Compounds Acting via Inhibition of TNF-α Production., 78 (4): [PMID:25735399] [10.1021/acs.jnatprod.5b00005] |
11. Ryu HW, Park YJ, Lee SU, Lee S, Yuk HJ, Seo KH, Kim YU, Hwang BY, Oh SR.. (2017) Potential Anti-inflammatory Effects of the Fruits of Paulownia tomentosa., 80 (10): [PMID:28968119] [10.1021/acs.jnatprod.7b00325] |
12. Hanáková Z, Hošek J, Kutil Z, Temml V, Landa P, Vaněk T, Schuster D, Dall'Acqua S, Cvačka J, Polanský O, Šmejkal K.. (2017) Anti-inflammatory Activity of Natural Geranylated Flavonoids: Cyclooxygenase and Lipoxygenase Inhibitory Properties and Proteomic Analysis., 80 (4): [PMID:28322565] [10.1021/acs.jnatprod.6b01011] |
13. Maruta H, Ahn MR.. (2017) From bench (laboratory) to bed (hospital/home): How to explore effective natural and synthetic PAK1-blockers/longevity-promoters for cancer therapy., 142 [PMID:28814374] [10.1016/j.ejmech.2017.07.043] |
Source(1):